Treatment of Recurrent or Metastatic Uterine Adenosarcoma

PURPOSE: This study retrospectively evaluated overall survival (OS) by treatment of recurrent or metastatic uterine adenosarcoma including surgery, radiation, chemotherapy, and hormonal therapy and evaluated OS and progression-free survival (PFS) after 1st line systemic chemotherapy. METHODS: 78 pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Nathenson, Michael J., Conley, Anthony P., Lin, Heather, Fleming, Nicole, Ravi, Vinod
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5763139/
https://www.ncbi.nlm.nih.gov/pubmed/29445312
http://dx.doi.org/10.1155/2017/4680273

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5763139/
https://www.ncbi.nlm.nih.gov/pubmed/29445312
http://dx.doi.org/10.1155/2017/4680273

Ejemplares similares